Skip to main content
Log in

Association between high plasma levels of legumain and cardiovascular events in patients undergoing coronary angiography

  • Short Communication
  • Published:
Heart and Vessels Aims and scope Submit manuscript

Abstract

Degradation of vascular extracellular matrix is important in atherosclerosis. Cysteine protease legumain is upregulated in atherosclerotic plaques. We recently reported that plasma legumain levels are high in patients with complex coronary lesions. This study investigated the association between legumain levels and cardiovascular events in 372 patients undergoing coronary angiography. Patients with acute coronary syndrome were excluded. Of the 372 patients, 225 had coronary artery disease (CAD). During a mean follow-up of 7.0 ± 4.3 years, cardiovascular events occured in 62 patients. Compared with 310 patients without events, 62 with events tended to have higher prevalence of complex lesions (15% vs. 10%). Notably, patients with events had higher legumain levels (median 5.51 vs. 4.90 ng/mL, P < 0.01) than those without events. A Kaplan-Meier analysis showed lower event-free survival in patients with legumain > 5.0 ng/mL than in those with ≤ 5.0 ng/mL (P < 0.01). In multivariate Cox regression analysis, legumain level was an independent predictor of cardiovascular events. The hazard ratio for legumain > 5.0 ng/mL for cardiovascular events was 2.18 (95%CI = 1.27–3.77, P < 0.01). Only among 225 patients with CAD, patients with events had higher legumain levels (5.49 vs. 4.73 ng/mL) than without events (P < 0.02). Legumain level was also a predictor of cardiovascular events in patients with CAD. Thus, high plasma legumain levels were associated with an increased risk of cardiovascular events in patients undergoing coronary angiography and those with stable CAD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  1. Lutgens SP, Cleutjens KB, Daemen MJ, Heeneman S (2007) Cathepsin cysteine proteases in cardiovascular disease. FASEB J 21:3029–3041

    Article  CAS  PubMed  Google Scholar 

  2. Liu J, Sukhova GK, Sun JS, Xu WH, Libby P, Shi GP (2004) Lysosomal cysteine proteases in atherosclerosis. Arterioscler Thromb Vasc Biol 24:1359–1366

    Article  CAS  PubMed  Google Scholar 

  3. Chen JM, Fortunato M, Stevens RA, Barrett AJ (2001) Activation of progelatinase A by mammalian legumain, a recently discovered cysteine proteinase. Biol Chem 382:777–783

    Article  CAS  PubMed  Google Scholar 

  4. Shirahama-Noda K, Yamamoto A, Sugihara K, Hashimoto N, Asano M, Nishimura M, Hara-Nishimura I (2003) Biosynthetic processing of cathepsins and lysosomal degradation are abolished in asparaginyl endopeptidase-deficient mice. J Biol Chem 278:33194–33199

    Article  CAS  PubMed  Google Scholar 

  5. Morita Y, Araki H, Sugimoto T, Takeuchi K, Yamane T, Maeda T, Yamamoto Y, Nishi K, Asano M, Shirahama-Noda K, Nishimura M, Uzu T, Hara-Nishimura I, Koya D, Kashiwagi A, Ohkubo I (2007) Legumain/asparaginyl endopeptidase controls extracellular matrix remodeling through the degradation of fibronectin in mouse renal proximal tubular cells. FEBS Lett 581:1417–1424

    Article  CAS  PubMed  Google Scholar 

  6. Papaspyridonos M, Smith A, Burnand KG, Taylor P, Padayachee S, Suckling KE, James CH, Greaves DR, Patel L (2006) Novel candidate genes in unstable areas of human atherosclerotic plaques. Arterioscler Thromb Vasc Biol 26:1837–1844

    Article  CAS  PubMed  Google Scholar 

  7. Mattock KL, Gough PJ, Humphries J, Burnand K, Patel L, Suckling KE, Cuello F, Watts C, Gautel M, Avkiran M, Smith A (2010) Legumain and cathepsin-L expression in human unstable carotid plaque. Atherosclerosis 208:83–89

    Article  CAS  PubMed  Google Scholar 

  8. Li W, Kornmark L, Jonasson L, Forssell C, Yuan XM (2009) Cathepsin L is significantly associated with apoptosis and plaque destabilization in human atherosclerosis. Atherosclerosis 202:92–102

    Article  CAS  PubMed  Google Scholar 

  9. Lunde NN, Holm S, Dahl TB, Elyouncha I, Sporsheim B, Gregersen I, Abbas A, Skjelland M, Espevik T, Solberg R, Johansen HT, Halvorsen B (2017) Increased levels of legumain in plasma and plaques from patients with carotid atherosclerosis. Atherosclerosis 257:216–223

    Article  CAS  PubMed  Google Scholar 

  10. Wu J, Wang W, Xie T, Chen Z, Zhou L, Song X, Kan H, Lv Y, Wu L, Li F, Yang D, Chen Y, Liu B, Zheng Y (2022) Identification of novel plasma biomarkers for abdominal aortic aneurysm by protein array analysis. Biomolecules 12:1853

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Yang H, He Y, Zou P, Hu Y, Li X, Tang L, Zhu Z, Tai S, Tu T, Xiao Y, Chen M, Wu C, Zhou S (2020) Legumain is a predictor of all-cause mortality and potential therapeutic target in acute myocardial infarction. Cell Death Dis 11:1014

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Lunde NN, Gregersen I, Ueland T, Shetelig C, Holm S, Kong XY, Michelsen AE, Otterdal K, Yndestad A, Broch K, Gullestad L, Nyman TA, Bendz B, Eritsland J, Hoffmann P, Skagen K, Gonçalves I, Nilsson J, Grenegård M, Poreba M, Drag M, Seljeflot I, Sporsheim B, Espevik T, Skjelland M, Johansen HT, Solberg R, Aukrust P, Björkbacka H, Andersen GØ, Halvorsen B (2020) Legumain is upregulated in acute cardiovascular events and associated with improved outcome: potentially related to anti-inflammatory effects on macrophages. Atherosclerosis 296:74–82

    Article  CAS  PubMed  Google Scholar 

  13. Umei TC, Kishimoto Y, Aoyama M, Saita E, Niki H, Ikegami Y, Ohmori R, Kondo K, Momiyama Y (2020) High plasma levels of legumain in patients with complex coronary lesions. J Atheroscler Thromb 27:711–717

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Kishimoto Y, Saita E, Ohmori R, Kondo K, Momiyama Y (2024) High plasma concentrations of vanin-1 in patients with coronary artery disease. Heart Vessels 39:10–17

    Article  PubMed  Google Scholar 

  15. Ambrose JA, Israel DH (1991) Angiography in unstable angina. Am J Cardiol 68:78B–84B

    Article  CAS  PubMed  Google Scholar 

  16. Kishimoto K, Saita Y, Ohmori E, Kondo R, Momiyama Y (2024) High plasma levels of endosialin and cardiovascular events in patients undergoing coronary angiography. Heart Vessels 2024 Jan 8. https://doi.org/10.1007/s00380-023-02353-7

  17. Anthony K, Akobeng (2007) Understanding diagnostic tests 3: receiver operating characteristic curves. Acta Paediatr 96:644–647

    Article  Google Scholar 

  18. Arima H, Kubo M, Yonemoto K, Doi Y, Ninomiya T, Tanizaki Y, Hata J, Matsumura K, Iida M, Kiyohara Y (2008) High-sensitivity C-reactive protein and coronary heart disease in a general population of Japanese: the Hisayama Study. Arterioscler Thromb Vasc Biol 28:1385–1391

    Article  CAS  PubMed  Google Scholar 

  19. Momiyama Y, Kawaguchi A, Kajiwara I, Ohmori R, Okada K, Saito I, Konishi M, Nakamura M, Sato S, Kokubo Y, Mannami T, Adachi H, Kario K, Iso H, Ohsuzu F, Tsushima M (2009) Prognostic value of plasma high-sensitivity C-reactive protein levels in Japanese patients with stable coronary artery disease: the Japan NCVC-Collaborative inflammation cohort study. Atherosclerosis 207:272–276

    Article  CAS  PubMed  Google Scholar 

  20. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group (2013) KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 3:1–150

    Google Scholar 

  21. Kunihiro Matsushita M, van der Velde BC, Astor M, Woodward AS, Levey PE, de Jong J, Coresh, Ron T, Gansevoort (2010) Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 375:2073–2081

    Article  PubMed  PubMed Central  Google Scholar 

  22. Bozkurt B, Coats AJS, Tsutsui H, Abdelhamid CM, Adamopoulos S, Albert N, Anker SD, Atherton J, Böhm M, Butler J, Drazner MH, Michael Felker G, Filippatos G, Fiuzat M, Fonarow GC, Gomez-Mesa JE, Heidenreich P, Imamura T, Jankowska EA, Januzzi J, Khazanie P, Kinugawa K, Lam CSP, Matsue Y, Metra M, Ohtani T, Francesco Piepoli M, Ponikowski P, Rosano GMC, Sakata Y, Seferović P, Starling RC, Teerlink JR, Vardeny O, Yamamoto K, Yancy C, Zhang J, Zieroth S (2021) Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart failure. Eur J Heart Fail 23:352–380

    Article  PubMed  Google Scholar 

  23. Gregersen I, Michelsen AE, Lunde NN, Åkerblom A, Lakic TG, Skjelland M, Ryeng Skagen K, Becker RC, Lindbäck J, Himmelmann A, Solberg R, Johansen HT, James SK, Siegbahn A, Storey RF, Kontny F, Aukrust P, Ueland T, Wallentin L, Halvorsen B (2020) Legumain in acute coronary syndromes: a substudy of the PLATO (platelet inhibition and patient outcomes) trial. J Am Heart Assoc 9:e016360

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Ambrose JA (1991) Prognostic implications of lesion irregularity on coronary angiography. J Am Coll Cardiol 18:675–676

    Article  CAS  PubMed  Google Scholar 

  25. Meuwissen M, van der Wal AC, Koch KT, van der Loos CM, Chamuleau SA, Teeling P, de Winter RJ, Tijssen JG, Becker AE, Piek JJ (2003) Association between complex coronary artery stenosis and unstable angina and the extent of plaque inflammation. Am J Med 114:521–527

    Article  PubMed  Google Scholar 

  26. Ellis S, Alderman EL, Cain K, Wright A, Bourassa M, Fisher L (1989) Morphology of left anterior descending coronary territory lesions as a predictor of anterior myocardial infarction: a CASS Registry Study. J Am Coll Cardiol 13:1481–1491

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

This study was supported by a grant from the Honjo International Scholarship Foundation. Financial funding was also provided by Pfizer Japan Inc. However, these sponsors had no role in the design, analysis, or interpretation of our study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yukihiko Momiyama.

Ethics declarations

Conflict of interest

Our study has no conflicts of interest to disclose.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Momiyama, Y., Kishimoto, Y., Saita, E. et al. Association between high plasma levels of legumain and cardiovascular events in patients undergoing coronary angiography. Heart Vessels (2024). https://doi.org/10.1007/s00380-024-02373-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00380-024-02373-x

Keywords

Navigation